Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis
Status:
Completed
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blind, placebo-controlled study to be conducted in
the United States in subjects with treatment-resistant pruritus diagnosed with atopic
dermatitis.